Furthermore, exogenous administration of IL-33 to KT-K19CreERT mice induced CCA development, suggesting that IL-33 cooperates with the effects of Kras and TGFβR2 mutation in the development of CCA. The gene discussed is KRAS; the disease is cholangiocarcinoma.